When AI Meets the Lab: KKB Leads Masterclass on AI for Drug Discovery
- me73274
- Jun 25
- 2 min read
AI | Life Sciences | Leadership | Drug Discovery | Science | Business

The intersection of Artificial Intelligence and pharmaceutical innovation is no longer a future possibility — it is today's competitive frontier. And for leaders in the Life Sciences sector, understanding this intersection is no longer optional.
I recently facilitated a Masterclass on AI for Drug Discovery — an intensive, insight-led session designed for management at EY, professionals, and business leaders; navigating the rapidly evolving world of AI-driven drug development.
What We Explored

The masterclass took participants through the full arc of AI's role in modern drug discovery — from molecule screening and target identification, to clinical trial design and regulatory considerations. But more importantly, we explored what this means for the leaders steering these decisions.
Key themes included:
How AI is compressing the drug discovery timeline from decades to years
The human-AI collaboration model — where machines accelerate, and humans lead
Building scientific credibility while communicating AI-enabled outcomes to business stakeholders
The leadership mindset required to champion innovation in a risk-averse regulatory environment
Simplification and breaking down the complexity
We spent time in simplifying this highly scientific and technical process so that the understanding is expanded beyond experts

Why This Matters to Me Personally
With over 33 years of experience in Pharma and Life Sciences — across markets in Asia and the Middle East — I have witnessed firsthand how breakthrough science often stalls at the leadership layer. The science advances, but the people leading it are not always equipped to drive adoption, build cross-functional alignment, or communicate value upward.
This masterclass was designed to close that gap.
The Room Was Electric
What was outstanding was the quality of people in the room. Participants were not passive learners — they were practitioners who brought their own questions, challenges, and a healthy dose of scepticism. That is exactly the environment where real learning happens.
At KKB, I believe that the future of Life Sciences leadership is not just about knowing the science. It is about having the Clarity to see where AI fits, the Conviction to champion it, and the Connection to bring your teams along for the journey.
That is the 3C Formula — applied to one of the most exciting frontiers in human health.
What's Next
If your Life Sciences team is navigating the AI adoption curve — and you need a facilitator who speaks both the language of science and the language of leadership — I would love a conversation.
📩 Reach me at me@kkb.works📞 +91 96060 96865
Or book a free 30-minute strategy session to explore how this program can be customised for your organisation.





Comments